Cite

HARVARD Citation

    Derderian, S. et al. (2022). Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer. Clinical and translational science. 15 (11), pp. 2597-2612. [Online]. 
  
Back to record